Back to LYEL
CITADEL ADVISORS LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
9
Latest value
$386K
Q3 2026
Peak value
$1M
First seen
Q2 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2026 | $239K |
| Q2 2026 | $263K |
| Q2 2026 | $251K |
| Q2 2026 | $239K |
| Q2 2026 | $263K |
| Q2 2026 | $251K |
| Q3 2026 | $244K |
| Q3 2026 | $1M |
| Q3 2026 | $386K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $386K | 39.4K | — | — |
| Q3 2026 | $1M | 106.7K | — | — |
| Q3 2026 | $244K | 24.9K | — | — |
| Q2 2026 | $251K | 17.9K | — | — |
| Q2 2026 | $263K | 18.7K | — | — |
| Q2 2026 | $239K | 17.0K | — | — |
| Q2 2026 | $251K | 17.9K | — | — |
| Q2 2026 | $263K | 18.7K | — | — |
| Q2 2026 | $239K | 17.0K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M